The history of the DNA-testing startup reads like a checklist of Silicon Valley clichés: founder squabbles, gobs of cash, a ...

The board of directors for 23andMe quit following disagreements over the CEO's plans to privatize the DNA testing company.

Personal information for nearly half of the popular genetic testing company's customers -- 6.9 million people -- were exposed ...

On Sept. 23, the board of directors at 23andMe, a prominent DNA testing company, announced their resignation following a series of disagreements with CEO Ann ...

The pioneering DNA testing firm has been struggling to stay afloat financially despite ambitious ventures to provide health ...

All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...

Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.

Me has agreed to pay $30 million after a class action suit was brought against the company for last year's data breach.

The board of Anne Wojcicki's genetic-testing company resigned earlier this week. This founder thinks he has a plan to save ...

On Monday, 23andMe Holding Co. (ME) stock saw a modest uptick, ending the day at $0.34 which represents no change from the prior close of $0.34. The stock opened at $0.36 and touched a low of $0.34 ...

By letter dated August 2, 2024, a Special Committee of the Board of Directors of 23andMe rejected that offer, noting that it "provide [d] no premium to the closing price per share on Wednesday, July ...

All seven independent directors of 23andMe’s board resigned on Tuesday, citing disagreements over the chief executive’s plan ...